- Home
- VERI vs MIST Comparison
VERI vs MIST Comparison
Compare VERI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERI
- MIST
- Stock Information
- Founded
- VERI 2014
- MIST 2003
- Country
- VERI United States
- MIST Canada
- Employees
- VERI N/A
- MIST N/A
- Industry
- VERI EDP Services
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- VERI Technology
- MIST Health Care
- Exchange
- VERI Nasdaq
- MIST Nasdaq
- Market Cap
- VERI 91.5M
- MIST 89.8M
- IPO Year
- VERI 2017
- MIST N/A
- Fundamental
- Price
- VERI $1.52
- MIST $1.45
- Analyst Decision
- VERI Strong Buy
- MIST Strong Buy
- Analyst Count
- VERI 3
- MIST 2
- Target Price
- VERI $4.00
- MIST $7.50
- AVG Volume (30 Days)
- VERI 1.4M
- MIST 2.2M
- Earning Date
- VERI 08-07-2025
- MIST 08-07-2025
- Dividend Yield
- VERI N/A
- MIST N/A
- EPS Growth
- VERI N/A
- MIST N/A
- EPS
- VERI N/A
- MIST N/A
- Revenue
- VERI $90,947,000.00
- MIST N/A
- Revenue This Year
- VERI $16.39
- MIST N/A
- Revenue Next Year
- VERI $22.99
- MIST N/A
- P/E Ratio
- VERI N/A
- MIST N/A
- Revenue Growth
- VERI N/A
- MIST N/A
- 52 Week Low
- VERI $1.22
- MIST $0.63
- 52 Week High
- VERI $5.64
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- VERI 51.83
- MIST 41.19
- Support Level
- VERI $1.42
- MIST $1.36
- Resistance Level
- VERI $1.56
- MIST $2.56
- Average True Range (ATR)
- VERI 0.11
- MIST 0.18
- MACD
- VERI 0.03
- MIST -0.07
- Stochastic Oscillator
- VERI 83.88
- MIST 9.99
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).